Filing Details
- Accession Number:
- 0001140361-14-016952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-17 12:29:55
- Reporting Period:
- 2014-04-15
- Filing Date:
- 2014-04-17
- Accepted Time:
- 2014-04-17 12:29:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380956 | Robert Kramer | 2273 Research Blvd Suite 400 Rockville MD 20850 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-04-15 | 2,500 | $24.00 | 109,872 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-16 | 47,689 | $24.36 | 62,183 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer. Mr. Kramer's direct holdings include restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan as well as shares acquired through private placement.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.68, inclusive
Billionaire Hedge Funds
